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One hundred fifty-five individuals at 50% risk of inheriting Huntington disease 
(HD) were given a questionnaire surveying their sociodemographic characteris- 
tics, experience with HD, and attitudes toward presymptomatic and prenatal 
testing in HD. About two-thirds (63.2%) of the persons indicated they would take 
a presymptomatic test even if no specific treatment was available. Although one- 
half (49%) of the respondents stated they would make use of a prenatal test, only 
43 % of these individuals would decide to terminate a heterozygous fetus. Presym- 
patomatic test results indicating carrier status would influence some of the re- 
spondents’ decisions about marriage and childbearing. This strong interest of at- 
risk persons to make use of both presymptomatic and prenatal diagnosis in HD 
indicates the need for well-organized testing programs. These programs must be 
designed to address the genetic, psychosocial, and ethical issues that may arise in 
the use of this type of genetic test. 
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INTRODUCTION 
Huntington disease (HD) is an adult-onset, neurodegenerative disorder charac- 
terized by autosomal dominant transmission [Conneally, 19841. The disease is untreat- 
able and undetectable until symptoms appear. Children of an affected individual are 
at 50% risk of having inherited the HD gene. Since the onset of the disease is usually 
in adult life, many at-risk persons are forced to make decisions regarding education, 
careers, marriage and children without knowing if someday they too will be affected 
by the disease Wexler, 19791. Over the years this burden of uncertainty has prompted 
a search for a reliable predictive test for HD. Recently, a restriction fragment length 
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polymorphism (RFLP) was identified that is closely linked to the HD gene locus and 
will allow presymptomatic and prenatal diagnosis in HD persons with the appropriate 
family structure and size [Gusella et al, 1983, 19841. 
Many studies were undertaken before the discovery of this genetic marker to 
assess the attitudes and interest of persons at-risk for HD toward predictive testing 
[Barette and Marsden, 1979; Stern and Eldridge, 1975; Teltscher and Polgar, 1981; 
Tyler and Harper, 19751. These studies predicted that between 56% and 80% of at- 
risk persons were in favor of a hypothetical predictive test for HD. A study conducted 
since the marker discovery found that 73% of at-risk persons wanted to be tested 
[Schoenfeld et al, 19841. 
Since use of the marker test is expected to begin soon, we have conducted a 
study attempting to assess the demand and impact of such a test in the State of 
Michigan. The influence that predictive testing in HD will have on attitidues toward 
marriage, childbearing, and pregnancy outcome were examined, and the relationships 
between social and demographic variables and those attitudes were tested. 
MATERIALS AND METHODS 
A 30-item anonymous questionnaire was distributed throughout the State of 
Michigan between January 1984 and August 1985. These questionnaires were sent to 
approximately 1,200 individuals on the mailing lists of the Michigan Chapter of the 
Huntington’s Disease Foundation of America (HDFA) and the Michigan Chapter of 
the National Huntington’s Disease Association (NHDA). Questionnaires were also 
distributed to HD relatives seen for genetic counseling at the University of Michigan’s 
Movement Disorders Clinic. Persons were asked to identify which of the following 
groups applied to them: a) affected by HD, b) 50% at risk (child of an affected 
parent), c) spouse of a person affected by HD; d) spouse of a person at 50% risk, e) 
25% at risk (grandchild of person with HD), and f) other. Of the 258 questionnaires 
that were returned 155 were completed by persons at 50% risk, 15 by affected 
individuals, 32 by spouses of HD patients, 34 by spouses of persons at 50% risk, 14 
by 25% at-risk individuals and 8 by others. 
The questionnaire included 22 multiple choice questions and 8 questions that 
required a numerical answer. Of these questions, 28 were appropriate for persons at 
50% risk for HD. The remaining two questions were aimed at HD and at-risk spouses 
only. This study will only examine the responses of the 155 questionnaires returned 
by those at 50% risk for HD. Responses of the other groups will not be analyzed until 
a larger sample can be collected. 
Subjects were asked about their social and demographic background and the 
sex, age of onset, age of diagnosis, and survivorship of their affected parent. 
Additional questions covered the following topics: 1) the age at which the subject 
learned the hereditary implication of HD; 2) the number of affected relatives; 3) the 
frequency of contact with affected relatives; 4) the subject’s best source of information 
about HD; 5 )  the subject’s attitude toward taking a presymptomatic test; 6)  the 
subject’s attitude toward having one’s child(ren) tested; 7) the effect of a positive 
presymptomatic test on subsequent decisions about marriage, childbearing, and preg- 
nancy outcome; 8) the subject’s attitude toward use of a prenatal test; and 9) the effect 
of a positive prenatal test on pregnancy outcome decisions. A chi-square analysis was 
performed to test the significance of association between the variables. 
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Questionnaires were received from 155 persons at 50% risk for Huntington 
disease. Most of the questionnaires were fully completed, although a number of 
respondents left some questions unanswered. 
Sociodemographic Information 
The sociodemographic information provided by the at-risk respondents is given 
in Table I. The mean age of these persons is 38.2 (SD = 13.8). Ten (9.7%) of the 
105 respondents who already had children, reported they planned to have more, with 
one (1.0%) respondent being uncertain, and 92 (89.3%) choosing not to increase 
their family size; 2 individuals did not complete this question. Respondents with 
offspring had a mean of 2.6 (SD = 1.3) children. Of the unmarried, childless 
respondents, 8 (30.8%) planned children in the future, 5 (19.2%) did not, and 13 
(50.0%) were uncertain. Among the childless, married respondents, 6 (33.3%) 
planned children in the future, 7 (38.9%) chose to remain childless, and 5 (27.8%) 
were uncertain. 
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Experience with Huntington Disease 
Ninety-three (60.0%) respondents had a mother affected by HD, 58 (37.4%) 
had an affected father, and 4 (2.6%) did not know which parent had been affected. 
Fifty-five (35.5%) had a living affected parent, while 96 (61.9%) reported a deceased 
affected parent; 4 (2.5%) individuals did not answer this question. The mean reported 
age-of-onset of the respondents’ affected parent was 42.2 yr (SD = 8.8), while the 
mean age of diagnosis was 47.7 yr (SD = 9.5). When asked if they had lived with 
their parent while he/she was affected, 107 (69.0%) respondents answered they had 
lived with the affected parent, 42 (27.1 %) had not, and 6 (3.9%) did not answer this 
question. 
Only one (0.7%) respondent had never known a relative affected by HD (due 
to adoption), while 57 (39.6%) knew 1 to 2 affected relative(s), 55 (38.2%) knew 3 
to 4 affected relatives, and 31 (21.5%) knew 5 or more affected relatives; 11 persons 
failed to respond to this question. 
The mean age at which the respondents learned about the hereditary implications 
of HD was at 20.7 yr (SD = 10.6). Seventy-five (51.4%) respondents learned that 
HD was hereditary before they became 18 years old. Of the respondents with children, 
62 (59.0%) had learned of the hereditary nature before having children. 
The respondents felt their best sources of information about HD were their own 
reading (29.3 %), their relatives (26.9%), lay organizations (23.7%), physicians 
(13.9%), other health professionals (4.1 %), and other sources (2.0%). 
Attitudes Toward Presymptomatic Testing 
In response to the question “If a reliable predictive test were to become available 
which would show whether or not you had the gene for HD, but no treatment was 
available, would you want to take this test?”, 98 (63.2%) responded yes, 24 (15.5%) 
said no, 30 (19.4%) were uncertain, and 3 (1.9%) did not respond to the question. 
However, asked if they would use the same test if treatment were available, 134 
(86.5%) responded yes, 3 (1.9%) responded no, 14 (9.0%) were uncertain, and 4 
(2.9%) did not complete the question. 
The sociodemographic and HD experience variables were examined to deter- 
mine whether any variable correlated using a chi-square analysis with one’s attitude 
toward presymptomatic testing. Of these, the number of affected relatives correlated 
positively with the number of individuals who desired to be tested in the case when 
no treatment for HD was available (p < .05). Also, the earlier the parent’s age of 
onset, the more willing the respondents were to take a predictive test (p < .05). All 
other variables tested were independent of the respondent’s attitude toward a pre- 
symptomatic test. 
Of those with children, 70 (66.7%) wanted them tested, 9 (8.6%) did not, and 
26 (24.8%) were uncertain. The age of the respondents was correlated with their 
attitude toward predictive testing in their children. The older the respondent, the more 
likely they were to want their children tested (p < .01). Since the age of the 
respondents’ children were not assessed, it could be assumed that the older the 
respondent, the older the respondents’ children. In the case of nonminor children the 
wishes of the parent would not be considered important. 
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Effects of a Positive Presymptomatic Test Result 
Asked how a positive test result would have (had) influenced the respondents’ 
decisions about marriage, 17 (11.0%) stated they would (will) have been deterred 
from marrying, 62 (40.0%) said they would not be deterred, 66 (42.6%) were unsure, 
and 10 (6.5 %) failed to respond to the question. No variable collected was associated 
with respondents’ attitudes toward marriage. 
Sixty-six (42.6%) said a positive test result would deter them from having 
children, 25 (16.1%) said it would not, 47 (30.3%) were unsure, and 17 (11.0%) 
failed to answer. Of the childless respondents planning to have children, 3 (21.4%) 
indicated they would be deterred by a positive test result, 4 (28.6%) would not, 4 
(28.6%) were uncertain, and 3 (21.4%) did not answer. Of at-risk persons with 
children planning to have more, one (10.0%) said they would be deterred by a 
positive result, 4 (40.0%) would not, and 5 (50.0%) were uncertain. Of respondents 
with children not planning to have more, 39 (42.4%) said a positive test result before 
they had had children would have deterred them, 17 (18.5%) would not have been 
deterred, 32 (34.8%) were unsure, and 4 (4.3%) did not complete the question. 
Two variables showed a significant correlation with one’s attitude toward 
childbearing after a positive presymptomatic test result. The level of education was 
correlated positively with a respondents’ indication that a positive test result would 
deter him/her from childbearing (p < .01). The number of affected relatives also 
correlated significantly with the respondents’ childbearing decisions. Those respond- 
ents with five or more affected relatives were more likely to be deterred from 
childbearing by a positive test result than those with less than five affected relatives 
(p < .05). 
If a pregnancy occurred after the respondent had had a positive test result, 73 
(41.1%) stated they would want to complete the pregnancy, 21 (13.5%) would 
terminate the pregnancy, 39 (25.2%) were unsure, and 22 (14.2%) failed to complete 
the question. A significant correlation was found when the responses were categorized 
by religious preference. Catholics were more likely to choose to complete a pregnancy 
than Protestants (p < .05); Protestants were four times as likely to favor pregnancy 
termination than the Catholics. The data also showed that persons who would not 
deter childbearing after the parent had a positive test were almost three times more 
likely to complete a pregnancy than those who chose to deter childbearing (p < .05). 
There were 22 (34.9%) of the deterred childbearing group who would complete the 
pregnancy, 21 (33.3%) who would terminate the pregnancy, and 20 (31.7%) who 
were unsure. In the undeterred group, 24 (96.0%) would complete the pregnancy, 0 
(0%) would choose an abortion, and 1 (4.0%) was unsure. Among those unsure of 
their childbearing decisions, 25 (58.1 %) would complete the pregnancy, 0 (0%) 
would want an abortion, and 18 (41.9%) were unsure. 
Attitudes Toward Prenatal Testing 
Seventy-six (49.0%) respondents said they would (or would have) use(d) a 
prenatal test if available, 20 (12.9%) stated they would not, 34 (21.9%) were 
uncertain, and 25 (16.1 %) did not complete the question. The only variable that 
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appeared to influence the respondents’ attitudes toward the use of a prenatal test was 
religious preference. Catholics differed little from the group as a whole or from 
Protestants as to the percentage choosing not to favor a prenatal test but showed a 
significant decrease compared to the other groups in the number favoring such a test 
and an increase in the number that was uncertain (p C .05). 
Effect of a Positive Prenatal Test 
When asked to make a decision about the outcome of a pregnancy if a prenatal 
test was positive, 52 (33.5%) indicated they would complete the pregnancy, 35 
(22.6%) stated they would want an abortion, 46 (29.7%) were unsure, and 22 (14.2%) 
did not complete the question. The responses of Catholics and Protestants to this 
question were very similar. 
Of the persons who said they would take a prenatal test, given a positive result 
17 (22.7%) indicated they would complete the pregnancy, 32 (42.7%) would choose 
an abortion, and 26 (34.7%) were uncertain about their decision. As expected, 
respondents with and without children were significantly more in favor of terminating 
a pregnancy when a prenatal HD test is positive than when deciding solely on the 
basis of their own positive test result (p < .001). This study did not ascertain the 
number of respondents that would choose to abort a pregnancy regardless of any 
predictive procedure. 
DISCUSSION 
This survey indicates that about two-thirds of the respondents plan to make use 
of a presymptomatic test for HD, even when no treatment for this disease is available. 
This finding is consistent with those of other similar studies [Barette and Marsden, 
1975; Schoenfeld et al, 1984; Stern and Eldridge, 1975; Teltscher and Polgar, 1981; 
Tyler and Harper, 19751. In the event that some kind of treatment becomes available 
the number of respondents requesting the test would increase dramatically. The two 
variables that correlated with a person’s desire to be tested were the number of 
affected people in one’s family and the parent’s age of onset. A person with many 
affected relatives may feel more at risk, or that their lives have been more impacted 
upon by HD, and thus have a greater need to know their own status. Respondents 
whose parent had an earlier onset also were more likely to want to be tested, 
suggesting that those who are at risk and anticipate an earlier onset in themselves, 
may have more of a need to know their status than individuals from families where 
most affected relatives had onset later in life. Although only 11 % of respondents with 
a positive test stated they would be deterred from marrying, almost one half were 
unsure about marriage suggesting that those who test positive are going to face 
increased uncertainty about important issues in their lives. 
Two-thirds of the respondents wanted their children to be tested. However, 
since our questionnaire did not ascertain what proportion of these children were 
minors, it was not possible for us to determine what the demand for the testing of 
minors will be. If there is a demand for the testing of minors this may create a conflict 
between the HD family and the testing center. In preliminary discussions about 
organizing a testing program, many centers including our own do not plan to test 
minors. A decision with such overwhelming implications for one’s future should only 
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be made by that person him/herself when they reach adulthood. The rearing of 
children whose parents know their HD status could be affected negatively. 
Almost one-half of respondents would be deterred from having children if the 
at-risk person had a positive test. However, of the respondents who actually plan to 
have more children, many fewer (16.7%) would be deterred from childbearing. It is 
interesting that most persons with completed families indicated they would not have 
had children having known of a positive presymptomatic test result. It is not known 
if these respondents would actually have felt this way before childbearing or if it is 
simply easier for them to choose this response retrospectively. However, although a 
precise estimate is difficult to make, the data suggest there will be a decrease in the 
number of children born to test-positive parents. 
When a person with a positive test result is faced with a pregnancy almost one 
half stated they would complete the pregnancy, few would choose an abortion, and 
almost one quarter were undecided. Also, although almost one half the respondents 
indicated they would (or would have) make use of a prenatal test, less than one-half’ 
of this group would choose to terminate a pregnancy when a positive prenatal result 
is obtained, about one quarter would choose to continue the pregnancy, and about one 
third was uncertain. These results indicate that the gene frequency in the next 
generation would be decrease to some extent by this selective abortion process. It also 
indicates a major area of concern in presymptomatic and prenatal testing. Many 
persons will be bearing children they know have 50% risk or have been identified as 
being probable HD heterozygotes. How parents will deal psychologically with this 
knowledge is unknown. Many children may have to grow up with the knowledge that 
they will have a fatal disease. Furthermore, the knowledge of the child’s HD status 
may negatively influence their upbringing. 
Although presymptomatic and prenatal diagnosis may answer some questions of 
the person at-risk for HD, they will likely create many other uncertainties. It is 
difficult to anticipate just how this test will affect the at-risk person, but testing centers 
need to be prepared to deal with these issues. Counseling needs to be provided to at- 
risk individuals during the decision-making and coping processes before the test, 
while waiting for the test result and afterwards. Not only should those with positive 
or uncertain test results receive posttest counseling, but those with negative test 
results should also since each test outcome is likely to have dramatic impact on one’s 
life. Those found not to have the gene may experience “survivor guilt” since they 
may have escaped the disease while close relatives may have not wexler, 19841. 
Much preparation needs to be undertaken to provide a comprehensive testing 
program for presymptomatic and prenatal testing. Centers should be prepared to 
address not only the genetic issues, but also the psychosocial issues facing persons at 
risk for HD, before any testing is implemented. 
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APPENDIX 
UNIVERSITY OF MICHIGAN 
SURVEY OF ATTITUDES TOWARD HUNTINGTON DISEASE TESTING 
PART A: TO BE COMPLETED BY EVERYONE. 
1. Who are you? 
a. affected with HD 
b. 50% at-risk for HD (child of an affected parent) 
c. spouse of person affected by HD 
d. spouse of person 50% at-risk for HD 
e. 25 % at-risk for HD (grandchild of an affected grandparent) 
2. What is your sex? 
a. male 
b. female 
3. What is your age? -years old. 
4. What is your marital status? 





5. How many children do you have? ___ 








8. If yes in #7, how many more children do you plan to have? ___ 
9. What is the highest level of education that you have completed? 
(circle only one). 
a. less than high school graduate 
b. high school graduate 
c. some college 
d. college graduate 
e. post-graduate 
f. vocational training 
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At what age did this parent first show signs of Huntington disease? 
a. years old 
b. uncertain 
At what age was this parent diagnosed with having Huntington disease? 
a. years old 
b. uncertain 
Is your affected parent living? 
a. yes 
b. no 
How old were you when you found out that HD is hereditary? 
years old. 
Did you live with your HD parent while he/she was affected? 
a. yes 
b. no 
How many people in your family have been affected by HD? ~ 
How many people in your family affected with HD have you interacted with 
on a fairly regular basis? ~ 
What has been your best source of information about HD? 
a. relatives 
b. physicians 
c. lay organizations (CCHD, NHDA, HDFA, etc.) 
d. own reading 
e. other health professional 
f. other (specify): 
If you have children, did you learn that HD was hereditary . . . 
a. before having children 
b. after having children 
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11. If a reliable predictive test were to become available which would show 
whether or not you had the gene for HD, but no therapy was available, would 













14. If this predictive test showed you have the gene for HD, what influence would 
this have (had) on your decisions about marriage? 
a. I would be deterred or would have been deterred from getting married. 
b. I would not be deterred or would not have been deterred from getting 
c. I am not sure how this information would influence my decision about 
married. 
marriage. 
15. If this predictive test showed that you had the gene for HD, what influence 
would this have (had) on your decisions about childbearing? 
a. I would be deterred or would have been deterred from having children. 
b. I would not be deterred or have been deterred from having children. 
c, I am unsure. 
16. If this predicitive test showed that you had the gene for HD and a pregnancy 
did occur, what would you want to do? 
a. I would want to complete the pregnancy. 
b. I would want to abort the pregnancy. 
c. I am unsure. 
17. If prenatal testing were available which would indicate whether or not a fetus 




18. If this prenatal test showed that the fetus had the gene for HD, what would 
you want to do? 
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a. I would want to complete the pregnancy. 
b. I would want to abort the pregnancy. 
c .  I am unsure. 
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